Nanjing Medlander Medical Technology Co. Ltd. A (688273) — Cash Flow-to-Debt Ratio
Nanjing Medlander Medical Technology Co. Ltd. A (688273) has a Cash Flow-to-Debt Ratio of 0.61x as of December 2024, meaning its operating cash flow of CN¥122.51 Million could theoretically repay 1% of its total liabilities (CN¥199.66 Million) in one year. See Nanjing Medlander Medical Technology Co. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Nanjing Medlander Medical Technology Co. Ltd. A Cash Flow-to-Debt Ratio (2020–2024)
Historical debt coverage capacity for Nanjing Medlander Medical Technology Co. Ltd. A across 5 annual periods. Also explore net asset momentum of Nanjing Medlander Medical Technology Co. to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Nanjing Medlander Medical Technology Co. Ltd. A (2020–2024)
Year-by-year debt coverage analysis for Nanjing Medlander Medical Technology Co. Ltd. A. For market capitalisation and broader financial context, see Nanjing Medlander Medical Technology Co. market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.61x | CN¥122.51 Million | CN¥199.66 Million | ▼ -28.9% |
| 2023 | 0.86x | CN¥136.91 Million | CN¥158.60 Million | ▼ -3.3% |
| 2022 | 0.89x | CN¥126.67 Million | CN¥141.96 Million | ▼ -30.3% |
| 2021 | 1.28x | CN¥148.60 Million | CN¥116.01 Million | ▼ -13.3% |
| 2020 | 1.48x | CN¥131.10 Million | CN¥88.69 Million | — |